A plain-language guide

sarcoidosis

What's known, what's still uncertain, and what's actively debated, written plainly, and built only from published medical research.

Growing map · 32 sourced statements Every statement names its source Updated 2026-08-04
Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. sarcoidosis is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What's sarcoidosis?

Sarcoidosis is a systemic granulomatous disorder of unknown cause. It most commonly affects the lungs but can involve many organs. Its hallmark on biopsy is small clusters of immune cells called non-caseating granulomas. Because no single cause or definitive test exists, it is largely a diagnosis of exclusion, made after ruling out look-alike conditions such as infection and lymphoma.

Also indexed asORPHA:797, MONDO:0019338
Features mapped19
Treatments mapped4
Published sources11
Last reviewed2026-08-04

Signs and symptoms

Weight loss

Unintended weight loss can occur in sarcoidosis as part of the body's response to ongoing inflammation, and sometimes because the disease affects organs involved in digestion. New or ongoing weight loss is worth reporting because it can signal more active disease.

Limited evidenceSource: PMID:27454307
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:7800197, ORPHA:797
Notesplain_language confirmed from PMID:7800197 via curation 2026-06-18 [carrie (curation)]. | regrounded primary ORPHA:797 -> PMID:27454307 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Ventricular tachycardia

when sarcoidosis affects the heart, ventricular tachycardia (a fast, abnormal rhythm starting in the lower chambers of the heart) is one of the recognised complications.

Limited evidenceSource: PMID:38923509
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:797
Notesplain_language confirmed from PMID:38923509 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:797 -> PMID:38923509 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Lymphadenopathy

Swollen lymph nodes, classically the lymph nodes in the center of the chest (bilateral hilar lymphadenopathy), are a common finding.

Limited evidenceSource: PMID:33807303
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42251500, ORPHA:797
Notesplain_language confirmed from PMID:42251500 via curation 2026-06-13. | regrounded primary ORPHA:797 -> PMID:33807303 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Heart block

when sarcoidosis affects the heart it can disrupt the heart's electrical signals, and high-degree atrioventricular block (a slowing or blocking of the signal between the upper and lower chambers) is one of the recognised complications.

Limited evidenceSource: PMID:38923509
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:797
Notesplain_language confirmed from PMID:38923509 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:797 -> PMID:38923509 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Pulmonary fibrosis

In a subset of people the lung disease advances to scarring (pulmonary fibrosis), which can reduce lung function and, in some, lead to pulmonary hypertension.

Limited evidenceSource: PMID:42202746
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:797
Notesplain_language confirmed from PMID:42202746 via curation 2026-06-13. | regrounded primary ORPHA:797 -> PMID:42202746 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Cough

A persistent dry cough is one of the most common symptoms of sarcoidosis, because the disease most often forms inflammatory clumps of cells (granulomas) in the lungs. In case series it is reported by roughly half of patients.

Limited evidenceSource: PMID:35230389
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:27758984, ORPHA:797
Notesplain_language confirmed from PMID:27758984 via curation 2026-06-18 [carrie (curation)]. | regrounded primary ORPHA:797 -> PMID:35230389 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Dyspnea

Shortness of breath (dyspnea) is a frequent symptom of sarcoidosis and usually reflects granulomas and, over time, scarring in the lungs. It often shows up with activity before it is noticeable at rest.

Limited evidenceSource: PMID:35230389
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:27758984, ORPHA:797
Notesplain_language confirmed from PMID:27758984 via curation 2026-06-18 [carrie (curation)]. | regrounded primary ORPHA:797 -> PMID:35230389 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Diabetes insipidus

when sarcoidosis affects the hypothalamic-pituitary axis (the brain's hormone-control centre), it can cause diabetes insipidus, a problem with regulating body water that leads to heavy urination and thirst.

Limited evidenceSource: PMID:33329977
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42286744, ORPHA:797
Notesplain_language confirmed from PMID:42286744 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:797 -> PMID:33329977 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Chest pain

chest pain can be one of the symptoms of pulmonary sarcoidosis, along with cough and shortness of breath.

Limited evidenceSource: PMID:35230389
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:797
Notesplain_language confirmed from PMID:35230389 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:797 -> PMID:35230389 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Fatigue

Fatigue is one of the most common and disabling symptoms of sarcoidosis, and it can persist even when the rest of the disease looks stable. It is not a sign of laziness or poor effort; it is part of the illness itself.

Limited evidenceSource: PMID:27454307
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:27758984, ORPHA:797
Notesplain_language confirmed from PMID:27758984 via curation 2026-06-18 [carrie (curation)]. | regrounded primary ORPHA:797 -> PMID:27454307 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Skin plaque

when sarcoidosis affects the skin it most commonly appears as pink-red to red-brown raised bumps and plaques (flat, thickened patches), often on the head and neck.

Limited evidenceSource: PMID:38245372
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:797
Notesplain_language confirmed from PMID:38245372 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:797 -> PMID:38245372 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Uveitis

Eye inflammation (uveitis) is a recognized feature and can occur alongside lung involvement and skin findings.

Limited evidenceSource: PMID:33807303
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:7800197, ORPHA:797
Notesplain_language confirmed from PMID:7800197 via curation 2026-06-13. | regrounded primary ORPHA:797 -> PMID:33807303 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Erythema nodosum

Tender red bumps on the shins (erythema nodosum) can appear, especially in an acute form called Löfgren's syndrome, which often has a good outlook.

Limited evidenceCurated reference: ORPHA:797
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42251500
Notesplain_language confirmed from PMID:42251500 via curation 2026-06-13.
Last reviewed2026-06-13

Fever

Some people with sarcoidosis have bouts of fever, often alongside joint pain. Fever can be part of the body's inflammatory response and is a common feature of the acute form known as Löfgren syndrome.

Limited evidenceSource: PMID:27454307
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:16617186, ORPHA:797
Notesplain_language confirmed from PMID:16617186 via curation 2026-06-18 [carrie (curation)]. | regrounded primary ORPHA:797 -> PMID:27454307 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Hypercalcemia

Sarcoidosis can raise the level of calcium in the blood (hypercalcemia) because the granulomas make extra active vitamin D, which pushes the body to absorb more calcium. High calcium can cause thirst, frequent urination, and kidney problems if it is not managed.

Limited evidenceSource: PMID:33807303
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:27758984, ORPHA:797
Notesplain_language confirmed from PMID:27758984 via curation 2026-06-18 [carrie (curation)]. | regrounded primary ORPHA:797 -> PMID:33807303 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Nephrocalcinosis

in sarcoidosis, a high blood calcium level that persists can lead to nephrocalcinosis (a build-up of calcium deposits in the kidneys).

Limited evidenceSource: PMID:35761015
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:797
Notesplain_language confirmed from PMID:35761015 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:797 -> PMID:35761015 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Kidney stone

in sarcoidosis, a high blood calcium level that persists can lead to kidney stones.

Limited evidenceSource: PMID:35761015
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:797
Notesplain_language confirmed from PMID:35761015 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:797 -> PMID:35761015 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Renal insufficiency

sarcoidosis can involve the kidneys, and a high blood calcium level can lead to acute kidney injury (a sudden drop in how well the kidneys filter) by narrowing the small arteries that supply them.

Limited evidenceSource: PMID:33807303
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:35761015, ORPHA:797
Notesplain_language confirmed from PMID:35761015 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:797 -> PMID:33807303 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Arthritis

Joint pain or inflammation (arthralgia or arthritis), often in the ankles, can occur, particularly in the acute Löfgren's pattern.

Limited evidenceSource: PMID:33807303
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42251500, ORPHA:797
Notesplain_language confirmed from PMID:42251500 via curation 2026-06-13. | regrounded primary ORPHA:797 -> PMID:33807303 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

How it is diagnosed

Sarcoidosis

Diagnosed using: serum angiotensin-converting enzyme level.

Limited evidenceSource: PMID:36872840
The source text this rests on
“No sensitive or specific biomarkers for diagnosis and prognosis exist, but there are several that can be used to support clinical decisions, such as serum angiotensin-converting enzyme levels, human leukocyte antigen types, and CD4 Vα2.3+ T cells in BALF.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:36872840 via curation 2026-06-25
Last reviewed2026-06-25

Sarcoidosis

Diagnosed using: tissue biopsy for noncaseating granulomas.

Limited evidenceSource: PMID:36872840
The source text this rests on
“Diagnosis is suggestive in a patient if one or more of the following is present: radiologic signs of sarcoidosis, evidence of systemic involvement, histologically confirmed noncaseating granulomas, sarcoidosis signs in bronchoalveolar lavage fluid (BALF), and low probability or exclusion of other causes of granulomatous inflammation.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:36872840 via curation 2026-06-25
Last reviewed2026-06-25

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

corticosteroids

Corticosteroids are central to managing sarcoidosis when treatment is needed, dampening the inflammation that forms granulomas. Not everyone requires treatment, since the disease can resolve on its own; the decision is individual and made with the care team.

Used to help with: Sarcoidosis.

Limited evidenceSource: PMID:42266437
The source text this rests on
“Corticosteroid therapy, although central to sarcoidosis management, indirectly predisposes to OSA through weight gain, fat redistribution, and myopathy.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:42266437 via curation 2026-06-13
Last reviewed2026-06-13

corticosteroids (mainstay)

corticosteroids are the mainstay of treatment in sarcoidosis for people with symptoms and severely affected or declining organ function.

Used to help with: Sarcoidosis.

Limited evidenceSource: PMID:36872840
The source text this rests on
“Corticosteroids remain the mainstay of treatment for symptomatic patients with severely affected or declining organ function.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:36872840 via curation 2026-06-25
Last reviewed2026-06-25

methotrexate

methotrexate is one of the steroid-sparing immunosuppressive medicines that may be used in sarcoidosis for people who do not improve enough on glucocorticoids or who have side effects from them.

Used to help with: Sarcoidosis.

Limited evidenceSource: PMID:35230389
The source text this rests on
“Patients without adequate improvement while receiving a dose of prednisone of 10 mg/d or greater or those with adverse effects due to glucocorticoids may be prescribed immunosuppressive agents, such as methotrexate, azathioprine, or an anti-tumor necrosis factor medication, either alone or with glucocorticoids combined with appropriate microbial prophylaxis for Pneumocystis jiroveci and herpes zoster.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:35230389 via curation 2026-06-25
Last reviewed2026-06-25

anti-TNF medication

an anti-tumor necrosis factor medication is one of the steroid-sparing options that may be used in sarcoidosis for people who do not improve enough on glucocorticoids or who have side effects from them.

Used to help with: Sarcoidosis.

Limited evidenceSource: PMID:35230389
The source text this rests on
“Patients without adequate improvement while receiving a dose of prednisone of 10 mg/d or greater or those with adverse effects due to glucocorticoids may be prescribed immunosuppressive agents, such as methotrexate, azathioprine, or an anti-tumor necrosis factor medication, either alone or with glucocorticoids combined with appropriate microbial prophylaxis for Pneumocystis jiroveci and herpes zoster.”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:35230389 via curation 2026-06-25
Last reviewed2026-06-25

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
No longer supportedLater, stronger evidence or guidance overturned this.

Where this comes from

This guide is built from 11 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

ORPHA:797 · Orphanet/HPO annotations for Sarcoidosis
PMID:27454307 · [Epidemiology and Clinical Presentation of Sarcoidosis].
PMID:33329977 · Hypothalamic-Pituitary Axis Dysfunction, Central Diabetes Insipidus, and Syndrome of Inappropriate Antidiuretic Hormone Secretion as the First Clinical Presentation of Neurosarcoidosis: Why Early Diagnosis and Treatment is Important?
PMID:33807303 · Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis.
PMID:35230389 · Diagnosis and Treatment of Pulmonary Sarcoidosis: A Review.
PMID:35761015 · Renal sarcoidosis.
PMID:36872840 · Sarcoidosis: Epidemiology and clinical insights.
PMID:38245372 · Cutaneous Sarcoidosis.
PMID:38923509 · Management of cardiac sarcoidosis.
PMID:42202746 · When the lung is at risk: diagnosis, manifestations, and complications of pulmonary sarcoidosis.
PMID:42266437 · Sarcoidosis and Obstructive Sleep Apnoea: An Intriguing Relationship.

Take it further

Printed, source-linked documents built from this condition's graph — ready to bring to an appointment or attach to a coverage request. Every claim carries its published source, the same as this guide.